GKWIM
ZBH icon

Gerber Kawasaki Wealth & Investment Management’s Zimmer Biomet ZBH Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-124
Closed -$17K – 1152
2021
Q3 		$17K Buy
+124
New +$18.2K ﹤0.01% 545

Other funds holding ZBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's ZBH Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 124 shares — an estimated $17K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in ZBH in Q3 2021 and held it in 1 quarter. The position peaked at $17K in Q3 2021. 999 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 124 Zimmer Biomet shares in Q4 2021, an estimated $17K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Zimmer Biomet in Q3 2021 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's Zimmer Biomet position peaked at $17K in Q3 2021.
  • 999 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.